Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04284579
Other study ID # IndonesiaUAnes50
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 27, 2019
Est. completion date November 30, 2019

Study information

Verified date February 2020
Source Indonesia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aimed to determinate effective dose 95 (ED95) intravenous cannulation in pediatric patient after induction of sevoflurane 8 vol%


Description:

Twenty-two subjects were given informed consent before study enrolled. Anesthesia was induced by 8% sevoflurane with 6 L flow of 100% oxygen. IV cannulation was attempted at 2 min in the first child in each group. The time for cannulation in the next child was stepped up or down by 15 s depending on positive or negative response, respectively, in the previous child. Children were recruited till a minimum of six pairs of failure-success sequence which was obtained in the group. The mean of midpoints of the failure-success sequence was calculated to obtain the time for cannulation in 50% of the group.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date November 30, 2019
Est. primary completion date July 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Year to 3 Years
Eligibility Inclusion Criteria:

- Age 1-3 year

- Physical state ASA I dan II

- Parents of patients who agreed to participate and sign informed consent.

Exclusion criteria:

- Patients with difficult airway

- There's allergic reaction or drug's side effect after induction

- There's cardiorespiratory problem such as anaphylactic shock, aritmia, severe hypotension, desaturation before-on-or after induction

Study Design


Related Conditions & MeSH terms

  • Movement After Intravenous Cannulation

Intervention

Device:
IV cannula
We measure the time duration needed for IV cannulation

Locations

Country Name City State
Indonesia Indonesia University Jakarta DKI Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

References & Publications (5)

Behne M, Wilke HJ, Harder S. Clinical pharmacokinetics of sevoflurane. Clin Pharmacokinet. 1999 Jan;36(1):13-26. Review. — View Citation

Kilicaslan A, Gök F, Erol A, Okesli S, Sarkilar G, Otelcioglu S. Response to Makkar and Singh's comment on our article 'Determination of optimum time for intravenous cannulation after induction with sevoflurane and nitrous oxide in children premedicated w — View Citation

Kumar KR, Sinha R, Chandiran R, Pandey RK, Darlong V, Chandralekha. Evaluation of optimum time for intravenous cannulation after sevoflurane induction of anesthesia in different pediatric age groups. J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):371-3 — View Citation

Schwartz D, Connelly NR, Gutta S, Freeman K, Gibson C. Early intravenous cannulation in children during sevoflurane induction. Paediatr Anaesth. 2004 Oct;14(10):820-4. — View Citation

Whalen FX, Bacon DR, Smith HM. Inhaled anesthetics: an historical overview. Best Pract Res Clin Anaesthesiol. 2005 Sep;19(3):323-30. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary ED50 in intravenous cannulation after sevoflurane induction using Dixon Up and Down Method 2 minutes